Propionibacterium granulosum

[[File:|250px|alt=|]] Authority:{{{subdivision_ranks}}}:

Propionibacterium granulosum
Kingdom:
Phylum:	Actinomycetota
Class:	Actinomycetia
Order:	Propionibacteriales
Family:	Propionibacteriaceae

Propionibacterium granulosum is a species of bacteria belonging to the genus Propionibacterium. It is a Gram-positive bacterium that is part of the normal microbiota of human skin. This article provides a comprehensive overview of P. granulosum, including its taxonomy, morphology, physiology, and clinical significance.

Taxonomy

Propionibacterium granulosum is classified within the domain Bacteria, phylum Actinomycetota, class Actinomycetia, order Propionibacteriales, family Propionibacteriaceae, and genus Propionibacterium. It is closely related to other species within the genus, such as Propionibacterium acnes.

Morphology

P. granulosum is a Gram-positive bacterium, which means it retains the crystal violet stain used in the Gram staining procedure. It appears as small, non-motile, rod-shaped cells. The cells are typically arranged singly or in short chains. P. granulosum is an anaerobic organism, meaning it does not require oxygen for growth, although it can tolerate its presence.

Physiology

P. granulosum is a facultative anaerobe, capable of surviving in both aerobic and anaerobic environments. It is a chemoorganotroph, deriving its energy from the fermentation of organic compounds. The bacterium produces propionic acid as a major metabolic end product, which is characteristic of the genus Propionibacterium.

Habitat

P. granulosum is commonly found on the human skin, particularly in sebaceous areas. It is part of the normal skin microbiota and plays a role in maintaining skin health by preventing colonization by pathogenic organisms.

Clinical Significance

While P. granulosum is generally considered a commensal organism, it can occasionally be associated with opportunistic infections. It has been isolated from cases of acne vulgaris, although it is less commonly implicated than Propionibacterium acnes. In rare instances, P. granulosum has been associated with endocarditis, prosthetic joint infections, and other invasive infections, particularly in immunocompromised individuals.

Diagnosis

The identification of P. granulosum in clinical specimens is typically achieved through culture and biochemical testing. The bacterium can be cultured on standard anaerobic media, and its identity can be confirmed by its characteristic morphology and biochemical profile.

Treatment

Infections caused by P. granulosum are generally treated with antibiotics. The bacterium is usually susceptible to a range of antibiotics, including penicillins, tetracyclines, and macrolides. The choice of antibiotic may depend on the site and severity of the infection, as well as the patient's overall health status.

Prevention

Preventive measures for infections associated with P. granulosum include maintaining good hygiene and skin care practices. In healthcare settings, adherence to aseptic techniques and infection control protocols can help reduce the risk of opportunistic infections.

Research

Ongoing research is focused on understanding the role of P. granulosum in the skin microbiome and its potential contributions to skin health and disease. Studies are also exploring the bacterium's interactions with the immune system and its potential use in probiotic therapies.

See also

• Propionibacterium acnes
• Skin microbiota
• Anaerobic bacteria